About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

PRISM BioLab Co.,LTD, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.

Thu Nov 14, 2024 3:30 pm JST Earnings

206A PRISM BioLab Co.,LTD 【J-GAAP】

Earnings Report

PRISM BioLab Co.,LTD <206A> [TSE-G] announced its financial results after the market closed on November 14th (15:30). The net loss (non-consolidated) for the fiscal year ending September 2024 expanded to a loss of 1.04 billion yen (compared to a loss of 526 million yen in the previous period). The result was better than the previously estimated deficit of loss of 1.16 billion yen. Furthermore, the company did not disclose the performance outlook for the fiscal year ending September 2025.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2024 305 -782 -831 -1,049 -33.5 0 Nov 14, 2024 J-GAAP
YoY 0.0% 0.0% 0.0% 0.0% 0.0%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2024 Guidance 300 -888 -914 -1,160 -32.3 0 Jul 2, 2024 J-GAAP
Sep, 2024 Results 305 -782 -831 -1,049 -33.5 0 Nov 14, 2024 J-GAAP
Revision Rate +1.7% +11.9% +9.1% +9.6% -3.9%

Current Period Guidance

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2024 305 -782 -831 -1,049 -33.5 0 Nov 14, 2024 J-GAAP
Sep, 2025 Guidance 0 Nov 14, 2024 J-GAAP
YoY

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 100 -209 -174 -233 -7.8 -209.0 Aug 14, 2024 J-GAAP
Jul - Sep, 2024 90 -239 -335 -480 -15.3 -265.6 Nov 14, 2024 J-GAAP
YoY

Related Articles